ArticleFrontiers in nutrition2025
Analysis of the burden of colorectal cancer attributable to high body mass index in 204 countries and regions worldwide from 1990 to 2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- An analysis of the burden of colorectal cancer caused by high body mass index in 204 countries and regions worldwide from 1990 to 2023.Journal of global health · 2026Article
- Global burden of lip and oral cavity cancer attributable to high alcohol consumption from 1990 to 2021.Frontiers in nutrition · 2025Article
- Temporal trends in cancer mortality attributable to high BMI in Asia: an age-period-cohort analysis based on GBD 1992-2021.Frontiers in endocrinology · 2025Article
- Attributable burden of high BMI-related gastrointestinal tract cancers among middle-aged and elderly populations globally, 1990-2021 and projected to 2050: analysis of GBD 2021.Frontiers in nutrition · 2025Article
- Impact of metabolic risk factors on colorectal cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.Frontiers in nutrition · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer (CRC) is the second most common malignancy and the third leading cause of cancer-related deaths globally. Numerous studies have established a link between high body mass index (BMI) and CRC. However, a detailed analysis of the global disease burden of CRC attributable to high BMI has been lacking. Objective: This study aimed to evaluate the spatiotemporal trends in mortality and disability-adjusted life years (DALYs) attributable to high BMI-related CRC at global, regional, and national levels from 1990 to 2021. Methods: Epidemiological data on the association between high BMI and CRC were extracted from the 2021 Global Burden of Disease (GBD) study. Data on mortality, DALYs, age-standardized mortality rate (ASMR), and age-standardized DALY rate (ASDR) were stratified by sex, year, age, country, and Socio-demographic Index (SDI). Estimated annual percentage changes (EAPC) were calculated to assess temporal trends in ASMR and ASDR attributable to high BMI from 1990 to 2021. Decomposition and frontier analyses were conducted to identify drivers of burden changes and top-performing countries. Inequality analysis was performed to assess burden disparities across different SDI levels. The Bayesian age-period-cohort (BAPC) model was used to predict disease burden up to 2050. Results: Deaths and DALYs related to high BMI-associated CRC showed a robust upward trend, more than doubling in absolute numbers since 1990. Without intervention, similar patterns are projected to continue over the next 29 years. East Asia exhibited the highest risk of CRC deaths and DALYs attributable to high BMI, with the heaviest burden observed in China and the United States. High SDI regions demonstrated a higher burden, while low SDI regions faced higher EAPC. Conclusion: This study highlights high BMI as a significant risk factor for CRC, with notable regional heterogeneity in disease burden. Stratification by SDI and health inequality analysis underscore the need for tailored preventive strategies and health interventions targeting high BMI, particularly in different SDI regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.